Mereo Biopharma Group Plc Revenue per Employee (MREO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Mereo Biopharma Group Plc  (NASDAQ: MREO)
 

Mereo Biopharma Group Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Mereo Biopharma Group Plc's Revenue per employee fell on a trailing twelve month basis to $ 12,821, below the company average number of $934,974.
Within the Healthcare sector Mereo Biopharma Group Plc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Mereo Biopharma Group Plc has 39 employees.


What is Sales per Employee Ratio?







MREO Revenue per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 12,821 12,821 12,821 12,821 -
MREO's Total Ranking # # # # #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 934,974 $ 934,974 $ 934,974
(Dec 31 2021)  



Financial Statements
Mereo Biopharma Group Plc's Revenue MRQ $ 0 Millions Visit MREO's Income Statement
Mereo Biopharma Group Plc's Revenues TTM $ 1 Millions Visit MREO's aggregate revenue growth
What are MREO's Sales? Visit MREO's Sales by Segment




Other Ratios
Mereo Biopharma Group Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MREO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MREO's Competitors
Revenue per Employee for MREO's Suppliers
Revenue per Employee for MREO's Customers

You may also want to know
MREO's Sales Growth Rates MREO's Pe Price to earnings ratio MREO's Receivables Turnover Ratio MREO's Stock Quote
MREO's Net Income Growth Rates MREO's Ps Price to Sales ratio MREO's Sales per Employee MREO's Asset Turnover Ratio
MREO's Net Margin MREO's Pb Price to Book ratio MREO's Financial Strength Ratios MREO's Dividend Payout Ratio
Date modified: 2026-07-07T12:18:12+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Crispr Therapeutics Ag  20,412.94 $ 4.103  Million 201 
Pluri Inc   19,981.48 $ 1.079  Million 54 
Mangoceuticals Inc   18,844.50 $ 0.415  Million 22 
China Pharma Holdings Inc  18,061.18 $ 3.992  Million 221 
Ataibeckley Inc   17,267.33 $ 3.488  Million 202 
Cardiff Oncology Inc   16,935.48 $ 0.525  Million 31 
Northwest Biotherapeutics Inc  14,257.14 $ 1.497  Million 105 
Sharps Technology Inc   13,686.21 $ 0.397  Million 29 
Absci Corp  13,114.29 $ 1.836  Million 140 
Roivant Sciences Ltd   11,013.33 $ 8.260  Million 750 
Skinvisible Inc   10,000.00 $ 0.020  Million
Silence Therapeutics Plc  9,534.09 $ 0.839  Million 88 
Lightwave Logic Inc   7,150.15 $ 0.243  Million 34 
Aclarion Inc   7,079.91 $ 0.078  Million 11 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.